Breast Cancer News and Research

Latest Breast Cancer News and Research

State roundup: Many states, cities cut retiree health benefit budgets; Feds to decide Georgia's benchmark benefits plan

As cash-strapped U.S. cities and states struggle to address gaping budget holes, a long-honored benefit for public-sector workers has come into the cross-hairs of budget cutters: retiree health insurance. A growing number of states and cities are eliminating or reducing health coverage for retirees, a benefit that has long fallen by the wayside for most private-sector workers.

16 Oct 2012

Computerized checklist helps physicians to prevent dangerous venous thromboembolisms or PE

A computerized checklist system designed to help physicians identify and use the best methods of preventing potentially deadly blood clots in hospitalized trauma patients dramatically reduced the number of these dangerous venous thromboembolisms (VTEs), new Johns Hopkins research suggests.

16 Oct 2012

Breast cancer… do you know who diagnoses you?

Australian women have a 1 in 9 lifetime risk of developing breast cancer and 1 in every 100 breast cancers occurs in men. In 2012, it is estimated that 14,610 women will be diagnosed with breast cancer, making it the most common cancer affecting women in Australia. However, despite this, few people realise that pathologists arguably play the most important role in the detection and treatment of breast cancer.

16 Oct 2012

HIV agent offers HER2-positive breast cancer hope

A drug used to treat HIV infection may be a new treatment line for patients with an aggressive type of breast cancer, US researchers believe.

15 Oct 2012

Loyola employees to be part of Pink Glove Dance contest

Loyola University Health System nurses and staff recently set aside time from their busy schedules to showcase their dancing talent in a Pink Glove Dance video. This video is part of the Pink Glove Dance phenomenon that is sweeping the nation in support of breast cancer research.

15 Oct 2012

Celgene receives FDA approval for ABRAXANE to treat non-small cell lung cancer

Celgene Corporation today announced the U.S. Food and Drug Administration (FDA) has approved ABRAXANE (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) for the first-line treatment of locally advanced or metastatic non-small cell lung cancer, in combination with carboplatin, in patients who are not candidates for curative surgery or radiation therapy.

15 Oct 2012

Curcumin can inhibit formation of prostate cancer metastases

Powdered turmeric has been used for centuries to treat osteoarthritis and other illnesses. Its active ingredient, curcumin, inhibits inflammatory reactions. A new study led by a research team at Ludwig-Maximilians-Universit-t (LMU) in Munich now shows that it can also inhibit formation of metastases.

13 Oct 2012

Research roundup: Addressing disparities in cancer diagnosis time, Medicare open season awareness

Researchers tested the effectiveness of using patient navigation programs with women who have abnormal breast or cervical cancer screenings. These programs aim to facilitate treatment by such things as arranging financial support, transportation to appointments, child care or interpreter services.

13 Oct 2012

BC Cancer Agency second prestigious Vancouver institution to install MILabs Molecular Imaging System

MILabs is pleased to announce that the BC Cancer Agency, located in Vancouver, British Columbia will install a MILabs U‐SPECT/CT system to expand their current molecular oncology imaging and research capabilities. The U‐SPECT/CT is able to deliver high resolution, sensitivity and scanning speed contributing to outstanding quantification results and the ability to detect heterogeneous molecular processes in tumors.

12 Oct 2012

Type 2 diabetes screening: an interview with Dr Simon Griffin, MRC Epidemiology Unit at Addenbrooke’s Hospital, Cambridge

Type 2 diabetes is a condition in which the body does not make sufficient insulin or the insulin it makes doesn’t work sufficiently well to maintain a normal level of blood glucose and so the blood glucose rises.

12 Oct 2012

Neurotensin as an indicator for poor health outcomes in women

The satiety hormone neurotensin may provide a novel biomarker for assessing risk for diabetes, cardiovascular disease, and breast cancer among women, report researchers.

12 Oct 2012

Bidirectional communication between breast cancer cells and nearby MSCs cause metastasis

In recent years investigators have discovered that breast tumors are influenced by more than just the cancer cells within them. A variety of noncancerous cells, which in many cases constitute the majority of the tumor mass, form what is known as the "tumor microenvironment."

12 Oct 2012

Nelfinavir slows progress of HER2-positive tumor cells

After screening more than 2,300 drugs for their ability to halt the growth of breast cancer cells, Johns Hopkins researchers have discovered that the anti-HIV drug nelfinavir slows the progress of HER2-positive tumor cells, even if they are resistant to other breast cancer drugs.

12 Oct 2012

AACR conference to focus on scientific and lifestyle strategies for cancer prevention

The American Association for Cancer Research will host the 11th Annual AACR International Conference on Frontiers in Cancer Prevention Research at the Hilton Anaheim from Oct. 16-19, 2012.

12 Oct 2012

Dana-Farber expert offers tips to reduce risk of breast cancer

According to the American Cancer Society, about one in eight women will develop breast cancer in her lifetime. This year, nearly 40,000 women in the United States will die from the disease.

12 Oct 2012

Legal-Bay to donate lawsuit funding sales for October to breast cancer awareness month

Legal-Bay, The Lawsuit Settlement Funding Company, announced today that they will be donating a portion of their October sales to assist with the fight of Breast Cancer for women.

11 Oct 2012

Clear link between neurotensin and CVD, type 2 diabetes and breast cancer

"It was surprising to find such a clear link to the risk of type 2 diabetes and cardiovascular disease as well as to breast cancer. Obesity is a common risk factor for all three conditions, but the connection with neurotensin is not explained by obesity or other known risk factors", says Professor Olle Melander from the Department of Clinical Sciences at Lund University, who is also a consultant at Sk-ne University Hospital.

11 Oct 2012

Obama campaign unleashes ads on Medicaid, link between Medicare and Romney's 47 percent comment

According to news reports, these ads are part of the Obama campaign's more urgent approach since last week's debate performance.

11 Oct 2012

NCI identifies method by which cancerous mRNA escapes the body's safeguards

In innumerable spy movies, the hero or a villain imprints a key in clay in order to later make an exact copy. In the body, the clay is messenger RNA, or mRNA, which imprints a gene and transfers the plans to a ribosome, where the mRNA's code is manufactured into a protein - the shady shop where the clay imprint becomes a key.

11 Oct 2012

Spanish and British scientists design new blood test to identify aggressive prostate cancer

Scientists from the Spanish National Cancer Research Centre (CNIO) in Madrid, along with British colleagues from the Institute for Cancer Research (ICR) and the Royal Marsden NHS Foundation Trust, have developed a test that studies genetic patterns in blood cells to detect advanced-stage prostate cancer.

10 Oct 2012

Breast Cancer News and Research

Latest Breast Cancer News and Research

State roundup: Many states, cities cut retiree health benefit budgets; Feds to decide Georgia's benchmark benefits plan

Computerized checklist helps physicians to prevent dangerous venous thromboembolisms or PE

Breast cancer… do you know who diagnoses you?

HIV agent offers HER2-positive breast cancer hope

Loyola employees to be part of Pink Glove Dance contest

Celgene receives FDA approval for ABRAXANE to treat non-small cell lung cancer

Curcumin can inhibit formation of prostate cancer metastases

Research roundup: Addressing disparities in cancer diagnosis time, Medicare open season awareness

BC Cancer Agency second prestigious Vancouver institution to install MILabs Molecular Imaging System

Type 2 diabetes screening: an interview with Dr Simon Griffin, MRC Epidemiology Unit at Addenbrooke’s Hospital, Cambridge

Neurotensin as an indicator for poor health outcomes in women

Bidirectional communication between breast cancer cells and nearby MSCs cause metastasis

Nelfinavir slows progress of HER2-positive tumor cells

AACR conference to focus on scientific and lifestyle strategies for cancer prevention

Dana-Farber expert offers tips to reduce risk of breast cancer

Legal-Bay to donate lawsuit funding sales for October to breast cancer awareness month

Clear link between neurotensin and CVD, type 2 diabetes and breast cancer

Obama campaign unleashes ads on Medicaid, link between Medicare and Romney's 47 percent comment

NCI identifies method by which cancerous mRNA escapes the body's safeguards

Spanish and British scientists design new blood test to identify aggressive prostate cancer

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Breast Cancer News and Research

Latest Breast Cancer News and Research

How does norepinephrine influence anxiety-related behaviours?

Transforming Lab Workflows with Cell Culture Automation

Building Bridges to Scalable Allogeneic Cell Therapy

Newsletters you may be interested in